Effects of Empagliflozin, One of Sglt2 Inhibitors, on Cardiovascular System in Extracorporeal Membrane Oxygenation Treated Diabetic Rats: from Gene Expression to Cardiovascular Dynamics

2022-08-012024-05-18https://scholars.lib.ntu.edu.tw/handle/123456789/708993Effects of Empagliflozin, One of Sglt2 Inhibitors, on Cardiovascular System in Extracorporeal Membrane Oxygenation Treated Diabetic Rats: from Gene Expression to Cardiovascular Dynamics